Group One Trading’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Hold
0
– -$12.3K – 7875
2023
Q2
– Sell
-1
Closed -$37.2K – 6282
2023
Q1
$34.5K Hold
1
– – ﹤0.01% 5135
2022
Q4
$68K Sell
1
-1
-50% -$56.5K ﹤0.01% 4773
2022
Q3
$152K Sell
2
-1
-33% -$70K ﹤0.01% 4399
2022
Q2
$173K Hold
3
– – ﹤0.01% 4434
2022
Q1
$302K Hold
3
– – ﹤0.01% 4360
2021
Q4
$156K Buy
3
+2
+200% +$167K ﹤0.01% 5340
2021
Q3
$172K Sell
1
-1
-50% -$129K ﹤0.01% 5335
2021
Q2
$320K Hold
2
– – ﹤0.01% 4723
2021
Q1
$298K Hold
2
– – ﹤0.01% 4583
2020
Q4
$434K Buy
+2
New +$309K ﹤0.01% 3393
2020
Q3
– Hold
0
– – – 4935
2020
Q2
– Hold
0
– – – 5638

Other funds holding GNPX

Group One Trading's GNPX Position: Q2 2026 in Review

Group One Trading held its Genprex (GNPX) position steady in Q2 2026 at 0 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #7468.

Group One Trading first reported a position in GNPX in Q3 2021 and has held it in 11 quarters since. The position peaked at $485K in Q1 2022. 17 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.

  • Group One Trading held 0 shares of Genprex worth $1 as of Q2 2026.
  • Group One Trading left its Genprex share count unchanged in Q2 2026.
  • Genprex made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7468 holding.
  • Group One Trading first reported a position in Genprex in Q3 2021 and has held it in 11 quarters since.
  • Group One Trading's Genprex position peaked at $485K in Q1 2022.
  • 17 funds tracked by Wall St. Rank held Genprex as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.